New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
More hospital days seen with antipsychotic use in Alzheimer disease

More hospital days seen with antipsychotic use in Alzheimer disease

(HealthDay)—Alzheimer disease patients who initiate treatment with antipsychotic medications spend more days hospitalized than those who do not initiate antipsychotics, according to a study recently p
Neurology April 10,2024
More hospital days seen with antipsychotic use in Alzheimer disease

More hospital days seen with antipsychotic use in Alzheimer disease

(HealthDay)—Alzheimer disease patients who initiate treatment with antipsychotic medications spend more days hospitalized than those who do not initiate antipsychotics, according to a study recently p
Neurology April 10,2024
Alzheimer's disease—why insulin is a new suspect

Alzheimer's disease—why insulin is a new suspect

by Christian Holscher,The ConversationCredit: AI-generated imageJohnson and Johnsonrecently announcedthat it was halting a clinical trial for a new Alzheimer's drug after safety
Neurology April 10,2024
Alzheimer's disease—why insulin is a new suspect

Alzheimer's disease—why insulin is a new suspect

by Christian Holscher,The ConversationCredit: AI-generated imageJohnson and Johnsonrecently announcedthat it was halting a clinical trial for a new Alzheimer's drug after safety
Neurology April 10,2024
Can Alzheimer's be stopped years before it starts?

Can Alzheimer's be stopped years before it starts?

by Erica Rheinschild,University of Southern CaliforniaCredit: AI-generated imageResearchers at the Keck School of Medicine of USC are tackling the sixth-leading cause of death in the United Stat
Neurology April 10,2024
Can Alzheimer's be stopped years before it starts?

Can Alzheimer's be stopped years before it starts?

by Erica Rheinschild,University of Southern CaliforniaCredit: AI-generated imageResearchers at the Keck School of Medicine of USC are tackling the sixth-leading cause of death in the United Stat
Neurology April 10,2024
Alzheimer's and cardiovascular disease share common genetics in some patients

Alzheimer's and cardiovascular disease share common genetics in some patients

by University of California, San FranciscoCredit: CC0 Public DomainGenetics may predispose some people to both Alzheimer's disease and high levels of blood lipids such as cholesterol, a
Neurology April 10,2024
Alzheimer's and cardiovascular disease share common genetics in some patients

Alzheimer's and cardiovascular disease share common genetics in some patients

by University of California, San FranciscoCredit: CC0 Public DomainGenetics may predispose some people to both Alzheimer's disease and high levels of blood lipids such as cholesterol, a
Neurology April 10,2024
Spread of tau protein measured in the brains of Alzheimer's patients

Spread of tau protein measured in the brains of Alzheimer's patients

by Karolinska InstitutetThe images show tau deposits in the brain of a patient with early-stage Alzheimer’s disease. The warm colours indicate regions of heavy deposition and the difference in sp
Neurology April 10,2024
Spread of tau protein measured in the brains of Alzheimer's patients

Spread of tau protein measured in the brains of Alzheimer's patients

by Karolinska InstitutetThe images show tau deposits in the brain of a patient with early-stage Alzheimer’s disease. The warm colours indicate regions of heavy deposition and the difference in sp
Neurology April 10,2024
Potential noninvasive treatment for Alzheimer's disease

Potential noninvasive treatment for Alzheimer's disease

by University of QueenslandCredit: University of QueenslandUltrasound can overcome some of the detrimental effects of aging and dementia without the need to cross the blood-brain barrier, researc
Neurology April 10,2024
Potential noninvasive treatment for Alzheimer's disease

Potential noninvasive treatment for Alzheimer's disease

by University of QueenslandCredit: University of QueenslandUltrasound can overcome some of the detrimental effects of aging and dementia without the need to cross the blood-brain barrier, researc
Neurology April 10,2024
Alzheimer's disease plasma biomarker contributes to postoperative delirium-like behavior in rodents

Alzheimer's disease plasma biomarker contributes to postoperative delirium-like behavior in rodents

by Brandon Chase,Massachusetts General HospitalCredit: CC0 Public DomainTauopathy is one of the hallmarks of Alzheimer's disease (AD) pathogenesis, and the phosphorylation of Tau at threonin
Neurology April 10,2024
Alzheimer's disease plasma biomarker contributes to postoperative delirium-like behavior in rodents

Alzheimer's disease plasma biomarker contributes to postoperative delirium-like behavior in rodents

by Brandon Chase,Massachusetts General HospitalCredit: CC0 Public DomainTauopathy is one of the hallmarks of Alzheimer's disease (AD) pathogenesis, and the phosphorylation of Tau at threonin
Neurology April 10,2024
Brain cells in Alzheimer's patients consume resources essential to neurotransmission

Brain cells in Alzheimer's patients consume resources essential to neurotransmission

by Weber Shandwick WorldwideCredit: Public DomainAlzheimer's disease (AD), the most common type of dementia, causes the death of neurons and leads to shrinking of the brain. Patients with AD
Neurology April 10,2024
Brain cells in Alzheimer's patients consume resources essential to neurotransmission

Brain cells in Alzheimer's patients consume resources essential to neurotransmission

by Weber Shandwick WorldwideCredit: Public DomainAlzheimer's disease (AD), the most common type of dementia, causes the death of neurons and leads to shrinking of the brain. Patients with AD
Neurology April 10,2024
A new culprit of cognitive decline in Alzheimer's disease

A new culprit of cognitive decline in Alzheimer's disease

by Julie Langelier,Gladstone InstitutesPET scan of a human brain with Alzheimer's disease. Credit: public domainIt has long been known that patients with Alzheimer's disease have abnorma
Neurology April 10,2024
A new culprit of cognitive decline in Alzheimer's disease

A new culprit of cognitive decline in Alzheimer's disease

by Julie Langelier,Gladstone InstitutesPET scan of a human brain with Alzheimer's disease. Credit: public domainIt has long been known that patients with Alzheimer's disease have abnorma
Neurology April 10,2024
Alzheimer's disease may cause vicious circle between brain network and immune cell dysfunctions

Alzheimer's disease may cause vicious circle between brain network and immune cell dysfunctions

by Sarah C.p. Williams,Gladstone InstitutesA new study by Gladstone scientists suggests that certain anti-epileptic or tau-reducing treatments could be promising for people in the early stages o
Neurology April 10,2024
Alzheimer's disease may cause vicious circle between brain network and immune cell dysfunctions

Alzheimer's disease may cause vicious circle between brain network and immune cell dysfunctions

by Sarah C.p. Williams,Gladstone InstitutesA new study by Gladstone scientists suggests that certain anti-epileptic or tau-reducing treatments could be promising for people in the early stages o
Neurology April 10,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com